Mondrian Investment Partners LTD Lifted Omega Protein (OME) Holding By $571,184; Veritone (VERI) Shorts Increased By 42.94%

February 15, 2018 - By Adrian Mccoy

Veritone Incorporated (NASDAQ:VERI) had an increase of 42.94% in short interest. VERI’s SI was 1.02M shares in February as released by FINRA. Its up 42.94% from 714,700 shares previously. With 1.40M avg volume, 1 days are for Veritone Incorporated (NASDAQ:VERI)’s short sellers to cover VERI’s short positions. The stock decreased 4.15% or $0.668 during the last trading session, reaching $15.412. About 90,387 shares traded. Veritone, Inc. (NASDAQ:VERI) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Mondrian Investment Partners Ltd increased Omega Protein (OME) stake by 14.62% reported in 2017Q3 SEC filing. Mondrian Investment Partners Ltd acquired 35,699 shares as Omega Protein (OME)’s stock declined 29.38%. The Mondrian Investment Partners Ltd holds 279,803 shares with $4.66M value, up from 244,104 last quarter. Omega Protein now has $494.54M valuation. The stock increased 0.23% or $0.05 during the last trading session, reaching $22. About 658,975 shares traded or 16.62% up from the average. Omega Protein Corporation (NYSE:OME) has declined 0.60% since February 15, 2017 and is downtrending. It has underperformed by 17.30% the S&P500.

Mondrian Investment Partners Ltd decreased Vishay (NYSE:VSH) stake by 20,105 shares to 223,388 valued at $4.20 million in 2017Q3. It also reduced Pldt Adr stake by 516,919 shares and now owns 5.06 million shares. Cae Inc. (NYSE:CAE) was reduced too.

Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.22, from 1.09 in 2017Q2. It turned negative, as 24 investors sold OME shares while 38 reduced holdings. 18 funds opened positions while 36 raised stakes. 17.65 million shares or 6.68% less from 18.91 million shares in 2017Q2 were reported. Group holds 0% of its portfolio in Omega Protein Corporation (NYSE:OME) for 14,785 shares. Grp One Trading Lp holds 2,414 shares. Vanguard invested in 910,775 shares or 0% of the stock. Advisory Services Ltd Liability Com stated it has 4,051 shares or 0.01% of all its holdings. Geode Cap holds 0% of its portfolio in Omega Protein Corporation (NYSE:OME) for 463,689 shares. Legal General Grp Public Llc invested in 6,122 shares or 0% of the stock. Ameriprise Finance stated it has 33,435 shares or 0% of all its holdings. Envestnet Asset Inc has 0% invested in Omega Protein Corporation (NYSE:OME). Wells Fargo & Mn holds 74,394 shares. Franklin Resources Inc reported 226,000 shares. Alphaone Invest Serv Ltd Liability Com has 0.02% invested in Omega Protein Corporation (NYSE:OME) for 4,546 shares. Numeric Ltd Company reported 0.07% in Omega Protein Corporation (NYSE:OME). Parametric Assoc Ltd Llc has 303,098 shares for 0.01% of their portfolio. 153,009 were reported by Jpmorgan Chase & Co. Commonwealth Equity Ser Incorporated has invested 0% in Omega Protein Corporation (NYSE:OME).

Among 6 analysts covering Omega Protein (NYSE:OME), 0 have Buy rating, 0 Sell and 6 Hold. Therefore 0 are positive. Omega Protein had 13 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has “Buy” rating by DA Davidson given on Tuesday, September 29. The rating was initiated by BB&T Capital with “Hold” on Tuesday, September 1. As per Monday, April 3, the company rating was maintained by Sidoti. The rating was downgraded by Wunderlich on Friday, August 5 to “Hold”. The firm has “In-Line” rating given on Tuesday, August 11 by Imperial Capital. DA Davidson downgraded the stock to “Neutral” rating in Monday, December 14 report. Wunderlich initiated it with “Buy” rating and $22 target in Thursday, April 28 report. Pivotal Research upgraded the stock to “Buy” rating in Wednesday, January 20 report. The stock of Omega Protein Corporation (NYSE:OME) earned “Hold” rating by Pivotal Research on Thursday, August 3. The stock of Omega Protein Corporation (NYSE:OME) has “Hold” rating given on Tuesday, October 20 by Pivotal Research.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: